Author:
Kumar Anup,Yadav Siddharth,Krishnappa RaghunathS,Gautam Gagan,Raghavan Narasimhan,Bakshi Ganesh,Prakash Gagan,Ahluwalia Puneet,Tamankar Ashwin,Surekha Sanjoy,Kumar Niraj,Kumar Sandeep,Mallya Ashwin,Saini Gagan,Singhal Manish,Mavuduru Ravimohan,Nayak Brusabhanu,Singh Prabhjot,Jaipuria Jiten,Kumar Vijoy,Rawal SudhirK,Gupta NarmadaPrasad
Reference8 articles.
1. OCEBM Levels of Evidence Working Group, The Oxford 2011 Levels of Evidence. Available from: http://www.cebm.net/index.aspx?o=5653. [Last accessed on 2018 Jan 12].
2. Epidemiology of prostate cancer in India;Jain;Meta Gene,2014
3. Cancer Today. Available from: https://gco.iarc.fr/today/home. [Last cited on 2019 Oct 31].
4. Prostate cancer in Asian men;Ito;Nat Rev Urol,2014
5. Cancer Tomorrow. Available from: http://gco.iarc.fr/tomorrow/home. [Last cited on 2019 Oct 31].
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 177Lu-PSMA-617 for metastatic prostate cancer in India;The Lancet Regional Health - Southeast Asia;2024-11
2. Poor Glycemic Control Affecting Screening of Prostate Carcinoma;Cureus;2024-04-21
3. Burden of Prostate Cancer, Prostate-specific Antigen Myths, and Optimal Prostate-specific Antigen Screening;UroCancer Clinics of India;2024-01
4. Re: Kumar A, Yadav S, Krishnappa RS, Gautam G, Raghavan N, Bakshi G, et al. The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary). Indian J Urol 2022;38:252-7;Indian Journal of Urology;2023
5. Author reply Re:Kumar A, Yadav S, Krishnappa RS, Gautam G, Raghavan N, Bakshi G, et al. The Urological Society of India guidelines for the evaluation and management of prostate cancer (executive summary). Indian J Urol 2022;38:252-257;Indian Journal of Urology;2023